15 filings · most recent first
VRTX 8-K Filings
Vertex Pharmaceuticals To Acquire Crinetics Pharmaceuticals For 10B
Vertex Pharmaceuticals Approves 2026 Stock And Option Plan
Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results And Pipeline
Vertex Pharmaceuticals Director Suketu Upadhyay To Depart Board
Vertex Pharmaceuticals Submits Rolling Bla For Povetacicept To Fda
Vertex Pharmaceuticals Reports Strong Q4 2025 Results And Provides 2026 Guidance
Vertex Pharmaceuticals Reports Third Quarter 2025 Financial Results And Revises
Vertex Pharmaceuticals Reports Strong Q2 2025 Financial Results And Key
Vertex Pharmaceuticals Announces Additional Stock Repurchase Program
Vertex Shareholders Reelect Board Members And Approve Key Proposals
Vertex Pharmaceuticals Reports Q1 2025 Financial Results And Raises Revenue
Vertex Pharmaceuticals Announces Impairment Charge For Discontinued Vx264
Vertex Announces Leadership Transition And Reports Q4 2024 Financial Results
Vertex Pharmaceuticals Announces Fda Approval For Alyftrek To Treat Cystic
Vertex Pharmaceuticals Raises Fullyear Revenue Guidance After Strong Q3